Israel Pharmaceuticals and Healthcare Report Q2 2014

Date: March 19, 2014
Pages: 141
Price:
US$ 1,295.00
Publisher: Business Monitor International
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: IC29E94DD9BEN
Leaflet:

Download PDF Leaflet

Includes 3 FREE quarterly updates

BMI View: Israel's pharmaceutical industry is well developed and export-driven. It is also a very attractive prospect for multinationals looking to launch innovative medicines due to a greater need for specialty treatments, thereby capitalising on the country's strong academic research infrastructure. Favourable factors include high per capita spending on medicines, a market size approaching US$2bn, a high proportion of pensioners and a largely urbanised population. However, we caution that poor patent respect and a lack of business transparency remain key threats to company revenues. Additionally, we hold a relatively less optimistic outlook for growth in the market, based on weaker private consumption over the medium term.

Headline Expenditure Projections
  • Pharmaceuticals: ILS7.31bn (US$2.02bn) in 2013 to ILS7.48bn (US$2.11bn) in 2014; +2.4% in local currency terms and 4.4% in US dollar terms. Forecast remains broadly in line with Q114.
  • Healthcare: ILS73.59bn (US$20.39bn) in 2013 to ILS78.32bn (US$22.12bn) in 2014; +6.4% in local currency terms and 8.5% in US dollar terms. Forecast lower than in Q114 due to impact of austerity measures.
BMI Industry View
SWOT Analysis
SWOT
Political
Economic
Business Environment
Industry Forecast
Pharmaceutical Market Forecast
  Table: Israel Pharmaceutical Sales, Historical Data And Forecasts
Healthcare Market Forecast
  Table: Israel Healthcare Expenditure Trends, Historical Data And Forecasts
  Table: Israel Government Healthcare Expenditure Trends, Historical Data And Forecasts
  Table: Israel Private Healthcare Expenditure Trends, Historical Data And Forecasts
Prescription Drug Market Forecast
  Table: Israel Prescription Drug Market Indicators, Historical Data And Forecasts
Patented Drug Market Forecast
  Table: Israel Patented Drug Market Indicators, Historical Data And Forecasts
Generic Drug Market Forecast
  Table: Israel Generic Drugs Market Indicators, Historical Data And Forecasts
OTC Medicine Market Forecast
  Table: Israel Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts
Pharmaceutical Trade Forecast
  Table: Israel Pharmaceutical Trade Data And Forecasts (US$mn)
  Table: Israel Pharmaceutical Trade Data And Forecasts (ILSmn)
Other Healthcare Data
Key Risks To BMI's Forecast Scenario
Macroeconomic Forecasts
Economic Analysis
  Table: Israel - GDP By Expenditure
Industry Risk Reward Ratings
Middle East And Africa Risk/Reward Ratings
Israel Risk/Reward Ratings
Reward
Risk
Market Overview
Market Overview
Industry Trends And Developments
Epidemiology
Communicable Diseases
Healthcare Sector
Healthcare Insurance
Healthcare Coverage Developments
Healthcare Financing
Healthcare Infrastructure
Research And Development Sector
  Table: Israel's R&D Legislation - Conditions For OCS Funding
Clinical Trials
Clinical Trial Developments
Biotechnology
Regulatory Development
Regulatory Developments
Intellectual Property
IP Environment Shortcomings
Pricing System
  Table: Price Build-Up In The Israeli Pharmaceutical Market
Reimbursement System
Reimbursement Developments
Competitive Landscape
Pharmaceutical Industry
Domestic Pharmaceutical Industry
Foreign Pharmaceutical Industry
Pharmaceutical Company Developments
Pharmaceutical Distribution Sector
Pharmaceutical Retail Sector
Company Profile
Teva Pharmaceutical Industries
Taro Pharmaceutical Industries
Perrigo (Adis Industries)
Dexcel Pharma
Neopharm Group
Trima
Rekah Pharmaceutical Industry
Pfizer
GlaxoSmithKline
Novartis
Sanofi
Merck & Co
Demographic Forecast
Demographic Outlook
  Table: Israel's Population By Age Group, 1990-2020 ('000)
  Table: Israel's Population By Age Group, 1990-2020 (% of total)
  Table: Israel's Key Population Ratios, 1990-2020
  Table: Israel's Rural/Urban Population Split, 1990-2020
Glossary
Methodology
Pharmaceutical Expenditure Forecast Model
Healthcare Expenditure Forecast Model
Notes On Methodology
Risk/Reward Ratings Methodology
Ratings Overview
  Table: Pharmaceutical Risk/Reward Ratings Indicators
Indicator Weightings

Ask Your Question

Israel Pharmaceuticals and Healthcare Report Q2 2014
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry: